Pyrazinamide
Top View
- RIFATER (Rifampin, Isoniazid and Pyrazinamide USP) Tablets
- TB Eliminationtreatment of Multidrug-Resistant Tuberculosis
- Reseptregisteret 2014–2018 the Norwegian Prescription Database 2014–2018
- Critically Important Antimicrobials for Human Medicine – 5Th Revision. Geneva
- ICCB-L Plate (10 Mm / 3.33 Mm) ICCB-L Well Vendor ID Chemical Name
- The Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in Singapore: Are Patients from South-East Asia Eligible?
- Towards Improved Treatment Outcomes for Tuberculosis Meningitis - Rethinking the Regimen
- Reactive Dirty Fragments: Implications for Tuberculosis Drug Discovery
- Tuberculosis Treatment Guidelines
- RIFATER® Rx Only (Rifampin, Isoniazid and Pyrazinamide USP)
- Methionine Antagonizes Para-Aminosalicylic Acid Activity Via Affecting 2 Folate Precursor Biosynthesis Pathway in Mycobacterium Tuberculosis
- Part 4 October 2017 Hydrochloride 150Mg/75Mg/400Mg/275Mg Film-Coated Section 7 Updated: April 2020 Tablets, (Micro Labs Limited), TB 223
- Antiinfectives Targeting Enzymes and the Proton Motive Force
- Chapter 6 Treatment of Tuberculosis Disease
- PYRAZINAMIDE TABLETS USP, 500 Mg Rx Only
- TB Elimination
- Section V. Treatment of Drug-Resistant Tuberculosis
- ICD-10-CM TABLE of DRUGS and CHEMICALS 2020